Maas Biolab scientists validate cyclosporin human neuroprotection
A very difficult-to-treat child leukemia may benefit from the discovery of a small but potent epigenetic change that launches the cancer - but could potentially be reversed relatively easily, preventing cancer-promoting genes from being turned on. The study, led by researchers at Children’s Hospital Boston and the Dana-Farber Cancer Institute, is the cover article in the
Full Post: Targeting epigenetic changes helps tackle MLL-AF4 leukemias
Maas Biolab researchers CSO Eskil Elmer, M.D., Ph.D. and neuroscientist Magnus Hansson, M.D., Ph.D., and colleagues have for the first time ever demonstrated the mitochondrial permeability transition (mPT) or “megapore” occurs in viable adult human neuron mitochondria and the ability of cyclosporin-A to block its formation.
These effects had previously been well characterized in animal neuroprotection studies and have now been validated in human brain tissue. The findings were presented at the Society for Neuroscience annual meeting in Washington, D.C. on Saturday, November 15, 2008. 32,000 attended this meeting, the premiere venue for world neuroscientists’ cutting-edge research.
Cyclosporin-A is neuroprotective through its effects on mitochondria. Attacked mitochondria normally stop making ATP and release toxic factors that activate caspases and apoptosis genes, killing the neuron. This cell death is caused by the formation of the mPT megapore. The mPT megapore can only form if it has cyclo philin -D available. Cyclosporin-A binds up all cyclophilin-D within each mitochondrion. Cyclosporin-A treated mitochondria continue to function normally, even while under attack, from conditions ranging from amyotrophic lateral sclerosis (ALS) to brain trauma. This is now confirmed in the human brain, reinforcing the expected effectiveness for cyclosporin-A in people with neurological diseases.
Cyclosporin-A is the active ingredient in Maas Biolab’s Mitogard intrathecal formula developed to treat ALS. Maas partner NeuroVive Pharmaceutical AB is producing NeuroSTAT, an intravenous cyclosporin-A formula for the treatment of traumatic brain injury. This research confirms cyclosporin-A is an effective human neuromitochondrial protectant.
Long thought of as mere bystanders, astrocytes are crucial for the survival and well-being of motor neurons, which control voluntary muscle movements. In fact, defective astrocytes can lay waste to motor neurons and are the main suspects in the muscle-wasting disease amyotrophic lateral sclerosis (ALS). To get to the root of this complicated relationship, researchers
Full Post: Researchers develop human embryonic stem cell-based system for modeling ALS
Dalhousie Medical School researchers have discovered that embryonic stem cells may play a critical role in helping people with nerve damage and motor neuron diseases, such as amyotrophic lateral sclerosis (ALS), regain muscular strength. Motor neurons reside in the spinal cord and control limb movements by enabling muscles to contract. Diseases like ALS cause them
Full Post: Researchers use embryonic stem cells from mice to grow motor neurons
A Mayo Clinic-led international consortium has found a mechanism that may help explain Parkinson’s and other neurological disorders. Studying just eight families worldwide, the international team of researchers have discovered a genetic defect that results in profound depression and parkinsonism in a disorder known as Perry syndrome. Although this syndrome is exceedingly rare, the mechanism
Full Post: Discovery of mechanism that may explain Parkinson’s and other neurological disorders
Wheat-based infant follow-on formulas are better reconstituted with fruit juice and should be stored in the fridge at 4?C to prevent growth of meningitis bacteria, according to recent research. The results of a study, published today in the Society for Applied Microbiology journal, Letters in Applied Microbiology, have shown that Cronobacter species do not grow
Full Post: New safety advice on wheat-based infant formula could prevent infant suffering
A new study by Narendra et al. suggests that Parkin, the product of the Parkinson’s disease-related gene Park2, prompts neuronal survival by clearing the cell of its damaged mitochondria. “[This is] an exciting new discovery that links the fields of mitochondrial quality control and the genetics of Parkinson’s disease (PD),” writes Heidi McBride of the
Full Post: Researchers shed new light on genetics of Parkinson’s